Cover Image
市場調查報告書

梅毒:全球臨床實驗檢討

Syphilis Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 175085
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
梅毒:全球臨床實驗檢討 Syphilis Global Clinical Trials Review, H1, 2015
出版日期: 2015年05月20日 內容資訊: 英文 75 Pages
簡介

本報告提供梅毒相關臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7與E7各國的臨床實驗狀況,各地區、Phase、階段別進行狀況,再彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,及有潛力的藥劑比較等資訊。

簡介

  • 梅毒
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量; 亞太地區
    • 主要國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區

G7各國的臨床實驗數量: 梅毒臨床實驗數量上感染疾病臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:梅毒臨床實驗數量上感染疾病臨床實驗數量所佔的比例

Phase別臨床實驗數量:E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 梅毒治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Pfizer Inc.
    • Mylan N.V.
    • Kendle International Inc. (Inactive)
    • F. Hoffmann-La Roche Ltd.
  • 有代表性的研究機關/醫院臨床實驗概要
    • Population Council
    • Centers for Disease Control and Prevention
    • The National Institute of Allergy and Infectious Diseases
    • Bronx Municipal Hospital Center
    • Chinese Academy of Medical Sciences and Peking Union Medical College
    • Far Eastern Memorial Hospital
    • L.A. Gay & Lesbian Center
    • National Taiwan University Hospital
    • Ottawa Hospital Research Institute
    • St. Joseph Hospital

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2684CTIDB

GlobalData's clinical trial report, "Syphilis Global Clinical Trials Review, H1, 2015" provides data on the Syphilis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Syphilis . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Syphilis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Syphilis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Syphilis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Mylan N.V.
      • Clinical Trial Overview of Mylan N.V.
      • Kendle International Inc. (Inactive)
      • Clinical Trial Overview of Kendle International Inc. (Inactive)
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Population Council
      • Clinical Trial Overview of Population Council
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Bronx Municipal Hospital Center
      • Clinical Trial Overview of Bronx Municipal Hospital Center
      • Chinese Academy of Medical Sciences and Peking Union Medical College
      • Clinical Trial Overview of Chinese Academy of Medical Sciences and Peking Union Medical College
      • Far Eastern Memorial Hospital
      • Clinical Trial Overview of Far Eastern Memorial Hospital
      • L.A. Gay & Lesbian Center
      • Clinical Trial Overview of L.A. Gay & Lesbian Center
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • St. Joseph Hospital
      • Clinical Trial Overview of St. Joseph Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Syphilis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan N.V., 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kendle International Inc. (Inactive), 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Population Council, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bronx Municipal Hospital Center, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese Academy of Medical Sciences and Peking Union Medical College, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Far Eastern Memorial Hospital, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by L.A. Gay & Lesbian Center, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph Hospital, 2015*

List of Figures

  • Syphilis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top